Tyler Zeronda - Mar 31, 2023 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Financial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol
VYNE
Transactions as of
Mar 31, 2023
Transactions value $
-$1,183
Form type
4
Date filed
4/4/2023, 05:07 PM
Previous filing
Jan 4, 2023
Next filing
Jul 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$1.18K -384 -4.52% $3.08 8.11K Mar 31, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.
F2 On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split.